PD-Rx Pharmaceuticals, Inc. (PDRX)
- Previous Close
4.9100 - Open
4.8900 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 7.5000 - Volume
1,771 - Avg. Volume
14 - Market Cap (intraday)
1 - Beta (5Y Monthly) -0.07
- PE Ratio (TTM)
0.00 - EPS (TTM)
1.0800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 13, 2018
- 1y Target Est
--
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company provides approximately 2,600 prepackaged medications; and creams, ointments, ophthalmics, otics, liquids, suspensions, etc. It also offers PD-Rx Net, a web-based application that tracks prescriptions filled at the point of care and print prescription labels for prescription that filled onsite; and manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a convenient handling package. In addition, the company provides professional assistance by staffed pharmacists and physicians; and pharmaceutical sampling program design to reduce MCO's pharmaceutical costs, as well as allows medical professionals to offer pre-filled prescriptions to patients free of charge. It serves physicians, pharmacies, and medical clinics. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma.
www.pdrx.comRecent News: PDRX
Performance Overview: PDRX
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PDRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PDRX
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.46%
Return on Assets (ttm)
-0.91%
Return on Equity (ttm)
-0.87%
Revenue (ttm)
21.27M
Net Income Avi to Common (ttm)
-98.06k
Diluted EPS (ttm)
1.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
104.55k
Total Debt/Equity (mrq)
31.31%
Levered Free Cash Flow (ttm)
1.38M
Research Analysis: PDRX
Company Insights: PDRX
PDRX does not have Company Insights